Skip to content

Child and Adolescent Registry for Participants With Narcolepsy

Children, Adolescents and Their Providers: the Narcolepsy Assessment Partnership (CATNAPTM)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04899947
Enrollment
500
Registered
2021-05-25
Start date
2020-10-10
Completion date
2024-10-01
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narcolepsy

Brief summary

CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.

Interventions

None listed

Sponsors

Jazz Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Any child or adolescent with a physician-confirmed diagnosis of narcolepsy * Age less than 18 years * Willing to participate in the Registry and complete the informed consent form * Able to participate in English based registry

Exclusion criteria

* Age 18 years or more * Fail to complete the informed consent form

Design outcomes

Primary

MeasureTime frame
Improve Understanding of Natural History of Pediatric NarcolepsyUp to 4 years
Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric ParticipantsUp to 4 years
Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for ChangesUp to 4 years

Secondary

MeasureTime frame
Patient Reported Outcomes Measurement Information System (PROMIS) Peer Relationship-Parent Proxy Short Form v2.0Up to 4 years
Caregiver Work Limitations Questionnaire (C-WLQ)Up to 4 years
Work Productivity and Activity Impairment (WPAI)Up to 4 years
Improvements in Quality of Life (QoL) as Measured by Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) QuestionnaireUp to 4 years
Change in Level of Social Support using the Social Support Survey InstrumentUp to 4 years
Change in Pittsburgh Sleep Quality index (PSQI) scoresUp to 4 years
Change in Caregiver Well-being Measured by the Caregiver Well-Being Scale (Shortened)Up to 4 years
QoL - Pediatric Quality of Life Inventory (PedsQL)Up to 4 years
Change in frequency of child ehavioral problems utilizing the Child Behavior Checklist (CBCL)Up to 4 years

Countries

United States

Contacts

Primary ContactDirector Clinical Trial Disclosure & Transparency
ClinicalTrialDisclosure@JazzPharma.com2158709177

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026